VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
VIEMED HEALTHCARE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$9.59+0.11 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $394.40M
- P/E (TTM)
- 26.6
- Dividend yield
- –
Share price
+$2.93 (+43.99%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
VIEMED HEALTHCARE, INC. grew revenue 25.2% to $301.61M over the twelve months to Jun 30, 2026. Operating income rose 8.3% to $22.77M, moving the operating margin from 8.7% to 7.5%. Free cash flow was $29.24M.
Revenue
$301.61M
+25.2% vs. a year earlier
Operating income
$22.77M
+8.3% vs. a year earlier
Free cash flow
$29.24M
TTM Q2 2026
EPS, diluted
$0.36
+5.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $394.40M
- P/E ratio
- 26.6
- Price to sales
- 1.31
- Price to book
- 2.74
- Dividend yield
- –
- Free cash flow yield
- 7.41%
Fundamentals
- Revenue
- $301.61M
- Net income
- $14.50M
- EPS, diluted
- $0.36
- Free cash flow
- $29.24M
- Book value per share
- $3.50
- Diluted shares
- 41M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
$301.61M+25.2% YoY
Gross profit
$173.32M+23.3% YoY
Operating income
$22.77M+8.3% YoY
Net income
$14.50M+3.7% YoY
EPS, diluted
$0.36+5.9% YoY
Free cash flow
$29.24M
Reported periodTrailing twelve months